These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 2145325)
21. Spaced clofazimine therapy of lepromatous leprosy. Am J Trop Med Hyg; 1976 May; 25(3):437-44. PubMed ID: 779502 [TBL] [Abstract][Full Text] [Related]
22. [Clofazimine and the eye]. Negrel AD; Baquillon G; de La Panouse A; Ducam M; Bagadec R; Chovet M Acta Leprol; 1981; (84):31-7. PubMed ID: 6797221 [No Abstract] [Full Text] [Related]
23. [Borderline lepromatous leprosy]. El Morabite K; Tbatou F; Ait Ourhroui M; Senouci K; Hassam B Presse Med; 2014 Jun; 43(6 Pt 1):733-4. PubMed ID: 24703733 [No Abstract] [Full Text] [Related]
24. Cutaneous disease and drug reactions in HIV infection. Krop LC; Johnson DP N Engl J Med; 1993 Nov; 329(21):1582; author reply 1582-3. PubMed ID: 8292166 [No Abstract] [Full Text] [Related]
25. Resolution of lepromatous leprosy after a short course of amoxicillin/clavulanic acid, followed by ofloxacin and clofazimine. Villahermosa LG; Walsh DS; Fajardo TT; Abalos RM; dela Cruz EC; Veerasubramanian P; Walsh GP Int J Dermatol; 1999 Jul; 38(7):558-60. PubMed ID: 10440294 [No Abstract] [Full Text] [Related]
26. Exfoliative dermatitis after clofazimine. Pavithran K Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):645-6. PubMed ID: 2935586 [No Abstract] [Full Text] [Related]
28. Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature. Ozturk Z; Tatliparmak A Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27549245 [TBL] [Abstract][Full Text] [Related]
29. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS. Tolentino JG; Rodriquez JN; Abalos RM Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720 [No Abstract] [Full Text] [Related]
30. Hyperpigmentation of the skin associated with minocycline therapy. Gordon G; Sparano BM; Iatropoulos MJ Arch Dermatol; 1985 May; 121(5):618-23. PubMed ID: 3158285 [TBL] [Abstract][Full Text] [Related]
31. A case of clofazimine enteropathy. Hameed A; Beach FX; Kennedy RH; Barry RE Int J Clin Pract; 1998 Sep; 52(6):439-40. PubMed ID: 9894387 [TBL] [Abstract][Full Text] [Related]
32. [Polyarthritis and papular eruption revealing leprosy]. Meyer M; Ingen-Housz-Oro S; Ighilahriz O; Wendling J; Gaulier A; Levy-Weil F; Sigal-Grinberg M; Flageul B Rev Med Interne; 2008 Mar; 29(3):242-5. PubMed ID: 17976874 [TBL] [Abstract][Full Text] [Related]
36. Clofazimine induced pigmentation in leprosy patches. Chavhan SD; Jawade S Pan Afr Med J; 2022; 42():14. PubMed ID: 35812254 [No Abstract] [Full Text] [Related]
37. Clofazimine induced enteropathy--a case highlighting the importance of drug induced disease in differential diagnosis. Mathew BS; Pulimood AB; Prasanna CG; Ramakrishna BS; Chandy SJ Trop Gastroenterol; 2006; 27(2):87-8. PubMed ID: 17089619 [TBL] [Abstract][Full Text] [Related]
38. Leprosy. Recognition and treatment. Ramos-e-Silva M; Rebello PF Am J Clin Dermatol; 2001; 2(4):203-11. PubMed ID: 11705247 [TBL] [Abstract][Full Text] [Related]
39. Annular vesiculobullous eruptions in type 2 reaction in borderline lepromatous leprosy: a case report. Kar HK; Raina A; Sharma PK; Bhardwaj M Indian J Lepr; 2009; 81(4):205-8. PubMed ID: 20704077 [TBL] [Abstract][Full Text] [Related]
40. A multicenter study of recombinant interferon-alpha 2b in the treatment of multibacillary leprosy. Ganapati R; Pai VV; Banerji U; Thomas J; Saha B Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):495-7. PubMed ID: 9465161 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]